Successful Tepotinib Treatment in MET Exon 14 Skipping Mutation‐Positive Lung Adenocarcinoma With Idiopathic Pulmonary Fibrosis Through Nintedanib Combination

Documenti analoghi

• Massive pleural effusion in porous diaphragm syndrome due to lymphatic leakage after pelvic surgery
  di: Masashi Nishimura, et al.
  Pubblicazione: (2024)
• MET Exon 14 Skipping Mutation‐Positive Lung Cancer With Multiple Cystic Airspaces: A Case Report
  di: Atsuki Asai, et al.
  Pubblicazione: (2026)
• Surgical lung biopsy for Idiopathic Pulmonary Fibrosis: Is the risk–benefit ratio changing
  di: Ian N. Glaspole, et al.
  Pubblicazione: (2024)
• Pre‐Treatment MMP7 Predicts Progressive Idiopathic Pulmonary Fibrosis in Antifibrotic Treated Patients
  di: Roger M. Li, et al.
  Pubblicazione: (2025)
• Association Between Single Nucleotide Polymorphisms and Disease Susceptibility, Survival, and Acute Exacerbation in Idiopathic Pulmonary Fibrosis
  di: Kazuya Tsubouchi, et al.
  Pubblicazione: (2025)